380 related articles for article (PubMed ID: 31740672)
1. Inhibition of DNA damage response at telomeres improves the detrimental phenotypes of Hutchinson-Gilford Progeria Syndrome.
Aguado J; Sola-Carvajal A; Cancila V; Revêchon G; Ong PF; Jones-Weinert CW; Wallén Arzt E; Lattanzi G; Dreesen O; Tripodo C; Rossiello F; Eriksson M; d'Adda di Fagagna F
Nat Commun; 2019 Nov; 10(1):4990. PubMed ID: 31740672
[TBL] [Abstract][Full Text] [Related]
2. Progerin-Induced Replication Stress Facilitates Premature Senescence in Hutchinson-Gilford Progeria Syndrome.
Wheaton K; Campuzano D; Ma W; Sheinis M; Ho B; Brown GW; Benchimol S
Mol Cell Biol; 2017 Jul; 37(14):. PubMed ID: 28483909
[TBL] [Abstract][Full Text] [Related]
3. Progerin reduces LAP2α-telomere association in Hutchinson-Gilford progeria.
Chojnowski A; Ong PF; Wong ES; Lim JS; Mutalif RA; Navasankari R; Dutta B; Yang H; Liow YY; Sze SK; Boudier T; Wright GD; Colman A; Burke B; Stewart CL; Dreesen O
Elife; 2015 Aug; 4():. PubMed ID: 26312502
[TBL] [Abstract][Full Text] [Related]
4. Transient introduction of human telomerase mRNA improves hallmarks of progeria cells.
Li Y; Zhou G; Bruno IG; Zhang N; Sho S; Tedone E; Lai TP; Cooke JP; Shay JW
Aging Cell; 2019 Aug; 18(4):e12979. PubMed ID: 31152494
[TBL] [Abstract][Full Text] [Related]
5. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.
Benson EK; Lee SW; Aaronson SA
J Cell Sci; 2010 Aug; 123(Pt 15):2605-12. PubMed ID: 20605919
[TBL] [Abstract][Full Text] [Related]
6. Dysfunction of iPSC-derived endothelial cells in human Hutchinson-Gilford progeria syndrome.
Matrone G; Thandavarayan RA; Walther BK; Meng S; Mojiri A; Cooke JP
Cell Cycle; 2019 Oct; 18(19):2495-2508. PubMed ID: 31411525
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D receptor signaling improves Hutchinson-Gilford progeria syndrome cellular phenotypes.
Kreienkamp R; Croke M; Neumann MA; Bedia-Diaz G; Graziano S; Dusso A; Dorsett D; Carlberg C; Gonzalo S
Oncotarget; 2016 May; 7(21):30018-31. PubMed ID: 27145372
[TBL] [Abstract][Full Text] [Related]
8. Hutchinson-Gilford progeria syndrome through the lens of transcription.
Prokocimer M; Barkan R; Gruenbaum Y
Aging Cell; 2013 Aug; 12(4):533-43. PubMed ID: 23496208
[TBL] [Abstract][Full Text] [Related]
9. Cellular stress and AMPK activation as a common mechanism of action linking the effects of metformin and diverse compounds that alleviate accelerated aging defects in Hutchinson-Gilford progeria syndrome.
Finley J
Med Hypotheses; 2018 Sep; 118():151-162. PubMed ID: 30037605
[TBL] [Abstract][Full Text] [Related]
10. Towards delineating the chain of events that cause premature senescence in the accelerated aging syndrome Hutchinson-Gilford progeria (HGPS).
Dreesen O
Biochem Soc Trans; 2020 Jun; 48(3):981-991. PubMed ID: 32539085
[TBL] [Abstract][Full Text] [Related]
11. Sulforaphane enhances progerin clearance in Hutchinson-Gilford progeria fibroblasts.
Gabriel D; Roedl D; Gordon LB; Djabali K
Aging Cell; 2015 Feb; 14(1):78-91. PubMed ID: 25510262
[TBL] [Abstract][Full Text] [Related]
12. Progerin impairs 3D genome organization and induces fragile telomeres by limiting the dNTP pools.
Kychygina A; Dall'Osto M; Allen JAM; Cadoret JC; Piras V; Pickett HA; Crabbe L
Sci Rep; 2021 Jun; 11(1):13195. PubMed ID: 34162976
[TBL] [Abstract][Full Text] [Related]
13. Metformin alleviates ageing cellular phenotypes in Hutchinson-Gilford progeria syndrome dermal fibroblasts.
Park SK; Shin OS
Exp Dermatol; 2017 Oct; 26(10):889-895. PubMed ID: 28192606
[TBL] [Abstract][Full Text] [Related]
14. Heterochromatin loss as a determinant of progerin-induced DNA damage in Hutchinson-Gilford Progeria.
Chojnowski A; Ong PF; Foo MXR; Liebl D; Hor LP; Stewart CL; Dreesen O
Aging Cell; 2020 Mar; 19(3):e13108. PubMed ID: 32087607
[TBL] [Abstract][Full Text] [Related]
15. Temsirolimus Partially Rescues the Hutchinson-Gilford Progeria Cellular Phenotype.
Gabriel D; Gordon LB; Djabali K
PLoS One; 2016; 11(12):e0168988. PubMed ID: 28033363
[TBL] [Abstract][Full Text] [Related]
16. Are There Common Mechanisms Between the Hutchinson-Gilford Progeria Syndrome and Natural Aging?
Ashapkin VV; Kutueva LI; Kurchashova SY; Kireev II
Front Genet; 2019; 10():455. PubMed ID: 31156709
[TBL] [Abstract][Full Text] [Related]
17. Farnesyltransferase inhibitor and rapamycin correct aberrant genome organisation and decrease DNA damage respectively, in Hutchinson-Gilford progeria syndrome fibroblasts.
Bikkul MU; Clements CS; Godwin LS; Goldberg MW; Kill IR; Bridger JM
Biogerontology; 2018 Dec; 19(6):579-602. PubMed ID: 29907918
[TBL] [Abstract][Full Text] [Related]
18. Vascular Smooth Muscle-Specific Progerin Expression Accelerates Atherosclerosis and Death in a Mouse Model of Hutchinson-Gilford Progeria Syndrome.
Hamczyk MR; Villa-Bellosta R; Gonzalo P; Andrés-Manzano MJ; Nogales P; Bentzon JF; López-Otín C; Andrés V
Circulation; 2018 Jul; 138(3):266-282. PubMed ID: 29490993
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Progerin Suppression and Lamin A Restoration Rescue Hutchinson-Gilford Progeria Syndrome.
Sánchez-López A; Espinós-Estévez C; González-Gómez C; Gonzalo P; Andrés-Manzano MJ; Fanjul V; Riquelme-Borja R; Hamczyk MR; Macías Á; Del Campo L; Camafeita E; Vázquez J; Barkaway A; Rolas L; Nourshargh S; Dorado B; Benedicto I; Andrés V
Circulation; 2021 Nov; 144(22):1777-1794. PubMed ID: 34694158
[TBL] [Abstract][Full Text] [Related]
20. Neuropeptide Y Enhances Progerin Clearance and Ameliorates the Senescent Phenotype of Human Hutchinson-Gilford Progeria Syndrome Cells.
Aveleira CA; Ferreira-Marques M; Cortes L; Valero J; Pereira D; Pereira de Almeida L; Cavadas C
J Gerontol A Biol Sci Med Sci; 2020 May; 75(6):1073-1078. PubMed ID: 32012215
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
